A few other genes have been reported to be activated by enhancer hijacking in AML, including BCL11B in acute leukemias with a mixed phenotype (17) and MNX1 in pediatric AML with t(7;12)(q36;p13) (18, 19). This evidence concerns the gene BCL11B and acute myeloid leukemia.